Evidence map›Paper›PMID 41211587›Full record

ReviewInternational journal of nanomedicine2025

Understanding the Molecular Toxicity of Metal-Based Nanoparticles Through Nanotoxicomics.

Jesús Gabriel González-Vega, Emilio Fabian-Ortiz, Jesús Hernández-Pérez, Silvia Hinojosa Alvarez, Rocio Alejandra Chavez Santoscoy

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jesús Gabriel González-Vega *School of Engineering and Science, Tecnologico de Monterrey, Monterrey, NL, Mexico.
Emilio Fabian-Ortiz *School of Engineering and Science, Tecnologico de Monterrey, Monterrey, NL, Mexico.
Jesús Hernández-PérezSchool of Engineering and Science, Tecnologico de Monterrey, Monterrey, NL, Mexico.
Silvia Hinojosa AlvarezSchool of Engineering and Science, Tecnologico de Monterrey, Monterrey, NL, Mexico.
Rocio Alejandra Chavez SantoscoySchool of Engineering and Science, Tecnologico de Monterrey, Monterrey, NL, Mexico.ORCID 0000-0002-4551-1862

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metal and metal oxide nanoparticles (NPs) are prevalent in industrial, medical, and consumer applications, yet concerns persist regarding their potential impact on human health. Traditional endpoint-based toxicological studies often face challenges in explaining the complex molecular mechanisms underlying the interactions between the physicochemical properties of NPs (eg, chemical composition, size, coating) and biological factors (eg, cell type). To address this gap, we introduce nanotoxicomics, a stepwise framework that integrates nanotoxicology with advanced omics technologies-transcriptomics, proteomics, and metabolomics. This approach enables multilevel analysis of NP effects, supporting the extrapolation of in vitro findings to tissues, organs, or whole systems. Moreover, this framework provides insights into the molecular mechanisms underlying consumer-product interactions and occupational exposure to NPs by enabling early detection of transcriptomic biomarkers, guiding downstream proteomic validation, and supplying metabolomic functional readouts that can be translated into potential clinical outcomes and enhanced risk assessment strategies. This review compiles and critically discusses evidence on the interactions of metal and metal oxide NPs with human cells and occupationally exposed populations. Key mechanisms include differential expression of genes related to oxidative stress, inflammation, and DNA damage (eg, SOD1, IL-6, MAP3K14, TP53), validation of protein biomarkers such as heat shock proteins and metallothioneins, and metabolite shifts reflecting ATP depletion, mitochondrial dysfunction, and redox imbalance (eg, GSH, PGE2, ATP). Finally, we highlight the value of nanotoxicomics and bioinformatics for designing safer NPs that can function as nanosensors, real-time monitoring agents, and drug delivery systems in nanomedicine, particularly in oncology, neurology, immunology, and cardiology. Overall, this study provides valuable insights into the molecular basis of metal and metal oxide nanoparticles and lays the groundwork for future research in predictive nanotoxicology, biomonitoring, and omics-driven risk assessment.

Indexed as

Metal NanoparticlesToxicologyAnimalsBiomarkersComputational BiologyDNA DamageGene Expression ProfilingGene Expression RegulationHumansInflammationMetabolomeMetabolomicsOccupational ExposureOxidative StressOxidesProteomeBiomarkersOxidesProteomemetabolomicsmetal-based nanoparticlesnanomaterialsnanotoxicologyoccupational exposureproteomicstranscriptomics

Identifiers

PMID41211587
PMCPMC12595969

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.